Search Results

Your search for Hagop Kantarjian, MD matches 2 pages

Showing 1 - 2

health-care policy

hematologic malignancies

leukemia

issues in oncology

cost of care

By The ASCO Post Staff / Friday, June 26, 2015 9:56 AM

Study Finds Current Prices of Hematologic Cancer Drugs Are Not Justified

The costs associated with cancer drug prices have risen dramatically over the past 15 years, a trend concerning to many oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded that the majority of existing treatments for hematologic cancers are...

issues in oncology

cost of care

By The ASCO Post Staff / Monday, March 23, 2015 2:47 PM

Experts Explore the Reasons Behind the High Cost of Cancer Drugs in America

Increasingly high prices for cancer drugs are affecting patient care, as well as the health-care system overall, in the United States. These findings were published in a special article by Rajkumar and Kantarjian in the journal Mayo Clinic Proceedings. “Americans with cancer pay 50% to 100%...

Apr

Today In Oncology

Search Results

Your search for Hagop Kantarjian, MD matches 2 pages

Study Finds Current Prices of Hematologic Cancer Drugs Are Not Justified

Experts Explore the Reasons Behind the High Cost of Cancer Drugs in America

Comparative Effectiveness of Acupuncture vs Massage for Relieving Pain in Patients With Advanced Cancer

Risk of Second Primary Breast Cancer in Young Breast Cancer Survivors

Adagrasib Plus Cetuximab in KRAS G12C–Mutated Colorectal Cancer

Improving Early Detection of Pancreatic Cancer in High-Risk Patients

Survival Rates in Patients With Cancer and Intellectual and Developmental Disabilities